The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Qiagen's revenues will grow 1.5% and EPS will wane -4.0%.
The average estimate for revenue is $311.8 million. On the bottom line, the average EPS estimate is $0.24.
Last quarter, Qiagen tallied revenue of $303.6 million. GAAP reported sales were 2.4% higher than the prior-year quarter's $296.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.23. GAAP EPS of $0.08 for Q1 were 33% lower than the prior-year quarter's $0.12 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 66.4%, 250 basis points better than the prior-year quarter. Operating margin was 13.5%, 240 basis points worse than the prior-year quarter. Net margin was 6.6%, 300 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $1.31 billion.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 175 members out of 188 rating the stock outperform, and 13 members rating it underperform. Among 58 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 56 give Qiagen a green thumbs-up, and two give it a red thumbs-down.
Looking for alternatives to Qiagen? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Qiagen to My Watchlist.